Transient adhesion of platelets in pump-oxygenator systems: influence of SMA and nitric oxide treatments.
We employed gamma scintigraphy to quantify the transient accumulations of platelets in pump-oxygenator systems employed in cardiopulmonary bypass (CPB). A flat sheet microporous polypropylene membrane oxygenator (Cobe Duo) was employed, with and without siloxane/caprolactone oligomer coating (SMA) (n = 8 each). The effect of nitric oxide gas infusion on platelet deposition was also evaluated for the uncoated Cobe Duo system (n = 10 each). Scintigraphic images of radiolabelled cells were obtained and converted to numbers of all platelets, labeled and unlabeled, adhering to the pump and oxygenator surfaces. These numbers were compared, by study group, for a 90-min period of normothermic CPB in the adult pig, employing standard prime and anticoagulation regimens. Platelets adhered in large numbers to control oxygenators, reaching maxima (> 20% of the circulating platelet mass) 30 min following institution of CPB, and decreasing for the duration of CPB. SMA treatment significantly decreased platelet adhesion following a 5-10-min transient accumulation period. Nitric oxide infusion significantly reduced platelet adhesion throughout the CPB period. Platelet accumulations on the high fluid shear centrifugal pump surfaces increased monotonically to maxima at about the same time as for the oxygenators, but did not decrease thereafter. Higher platelet surface densities were observed on the centrifugal pump surfaces than on the oxygenator surfaces. CPB with the untreated circuit tended to reduce circulating platelet counts vs theoretical values based on hemodilution alone. In contrast, SMA significantly increased the circulating platelet count versus the untreated control group. These results indicate that platelet adherence to the foreign surfaces of CPB equipment are influenced in characteristic ways by time and fluid shear. SMA treatment and nitric oxide infusion both reduce platelet adhesion to oxygenator surfaces. SMA treatment spares these cells for the circulation.
Li
J
J
Joint Biomedical Engineering Program, University of Texas Southwestern Medical Center at Dallas, 75235-9130, USA.
Sly
M K
MK
Chao
R
R
Constantinescu
A
A
Kulkarni
P V
PV
Wians
F H
FH
Jessen
M E
ME
Eberhart
R C
RC
D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D002448:Cell Adhesion; D006400:Hematocrit; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism / Q000627:therapeutic use; D010106:Oxygenators / Q000009:adverse effects*; D011108:Polymers / Q000378:metabolism*; D011126:Polypropylenes / Q000378:metabolism; D012833:Siloxanes / Q000378:metabolism / Q000627:therapeutic use; D013552:Swine; D013997:Time Factors
D011108:Polymers; D011126:Polypropylenes; D012833:Siloxanes; D009569:Nitric Oxide